Elsevier.com | MedConnect.com.au | Medconnect.com.sg | Lancet.cn | JOA中文版

通过UBB+1表达长期抑制转基因小鼠蛋白酶可使中枢呼吸控制功能失调——使人联想起阿尔茨默病中脑干神经病理

Long-term proteasomal inhibition in transgenic mice by UBB+1 expression results in dysfunction of central respiration control reminiscent of brainstem neuropathology in Alzheimer patients
2012-07-13 17:40点击:15次发表评论
作者:Martin Irmler1, Romina J. G. Gentier2, Frank J. A.
期刊: ACTA NEUROPATHOL2012年7月1期124卷

Abstract  
Aging and neurodegeneration are often accompanied by a functionally impaired ubiquitin–proteasome system (UPS). In tauopathies and polyglutamine diseases, a mutant form of ubiquitin B (UBB+1) accumulates in disease-specific aggregates. UBB+1 mRNA is generated at low levels in vivo during transcription from the ubiquitin B locus by molecular misreading. The resulting mutant protein has been shown to inhibit proteasome function. To elucidate causative effects and neuropathological consequences of UBB+1 accumulation, we used a UBB+1 expressing transgenic mouse line that models UPS inhibition in neurons and exhibits behavioral phenotypes reminiscent of Alzheimer’s disease (AD). In order to reveal affected organs and functions, young and aged UBB+1 transgenic mice were comprehensively phenotyped for more than 240 parameters. This revealed unexpected changes in spontaneous breathing patterns and an altered response to hypoxic conditions. Our findings point to a central dysfunction of respiratory regulation in transgenic mice in comparison to wild-type littermate mice. Accordingly, UBB+1 was strongly expressed in brainstem regions of transgenic mice controlling respiration. These regions included, e.g., the medial part of the nucleus of the tractus solitarius and the lateral subdivisions of the parabrachial nucleus. In addition, UBB+1 was also strongly expressed in these anatomical structures of AD patients (Braak stage #6) and was not expressed in non-demented controls. We conclude that long-term UPS inhibition due to UBB+1 expression causes central breathing dysfunction in a transgenic mouse model of AD. The UBB+1 expression pattern in humans is consistent with the contribution of bronchopneumonia as a cause of death in AD patients.
Electronic supplementary material  The online version of this article (doi:10.1007/s00401-012-1003-7) contains supplementary material, which is available to authorized users.

Keywords  Alzheimer’s disease (AD) – Mouse model – Ubiquitin B (UBB+1) – Ubiquitin–proteasome system (UPS) – Hypoxic response – Central breathing control

Abbreviations  Ub 
Ubiquitin
UBB 
Ubiquitin B
UBB+1  
Mutant ubiquitin B+1
UPS 
Ubiquitin–proteasome system
AD 
Alzheimer’s disease
PD 
Parkinson’s disease
APP 
Amyloid precursor protein
Ti/TT 
Relative duration of inspiration
AP 
Area postrema
IC 
Inferior colliculus
LC 
Locus coeruleus
ll 
Lateral lemniscus
NTS 
Nucleus of the tractus solitarius
PBN 
Nucleus parabrachialis
PBNcl 
Nucleus parabrachialis central lateral
PBNdl 
Nucleus parabrachialis dorsolateral
PBNel 
Nucleus parabrachialis external lateral
PBNem 
Nucleus parabrachialis external medial
PBNl 
Lateral parabrachial nucleus
PBNm 
Medial parabrachial nucleus
PBNvl 
Nucleus parabrachialis ventrolateral
scp 
Superior cerebellar peduncle
sol 
Solitary tract
SAG 
Sagulum
SolDL 
Nucleus of the tractus solitarius, dorsolateral part
SolM 
Nucleus of the tractus solitarius, medial part
SPP 
Subpeduncular pigmented nucleus
Sp5 
Spinal 5 nucleus
10N 
Dorsal motor nucleus of the vagus nerve
12N 
Hypoglossal nucleus
IV 
Fourth ventricle
M. Irmler and R. J. G. Gentier contributed equally. F. W. Van Leeuwen and J. Beckers are combined last authors.

Introduction

In eukaryotic cells, the function of complex protein networks is maintained by highly conserved pathways that regulate the selective degradation of proteins in a spatially and temporally organized manner. For example, the ubiquitin–proteasome system (UPS) contributes considerably to protein quality control together with the autophagy-lysosomal system. The UPS relies on the tagging of proteins destined for breakdown by the attachment of polyubiquitin chains and the subsequent translocation and degradation by proteasomes. The coupling of polyubiquitin chains to proteins is mediated by a cascade of E1, E2 and E3 proteins [21], where specificity is brought about by a large number of E3 ligases (>600). The complexity of the UPS is further increased by various deubiquitination enzymes (>90), the length and linkage type of the polyubiquitin chains, as well as by several ubiquitin-like proteins. In neuronal cells, the UPS is required for both pre- and postsynaptic processes [1237]. As a consequence, axonal outgrowth, long-term potentiation, and memory formation are critically dependent on a functional UPS [43].

Mutations in UPS genes have been associated with the pathogenesis of neurodegenerative and other brain diseases. For example, defects in the E3 ligase Park2 are causative for familiar forms of Parkinson’s disease (PD) [26]. Loss-of-function alleles of the deubiquitinase ubiquitin C-terminal hydrolase (UCHL1) are associated with the two most prevalent neurodegenerative diseases, PD and AD [34]. Both diseases are also characterized by the presence of ubiquitin (Ub) in disease-specific aggregates [30] and by a partial impairment of the UPS in general [1825], as is also observed in the elderly where age-related neurodegeneration is most prevalent. Despite the strong correlation between the UPS, Ub-containing cellular deposits and neurodegeneration, little is known about the impact of UPS inhibition on disease onset or progression. However, the presence of a mutant form of ubiquitin B, the UBB+1protein, in disease-specific aggregates (e.g., neurofibrillary tangles and intranuclear inclusions) of patients suffering from tauopathies and polyglutamine diseases [710] may point to a causative role of UPS dysfunction in these diseases rather than being a consequence. UBB+1 mRNA is formed at a low level [17] during transcription from the ubiquitin B (UBB) locus by a process called “molecular misreading” [38]. Dinucleotide deletions (ΔGU) in the Ubb transcripts occur just next to a GAGAG motif and result in a +1 reading frame shift and an altered protein sequence [39]. The resulting UBB+1 protein has a 20-residue extension and lacks the C-terminal glycine residue required for conjugation to target proteins for degradation. In the elderly, UBB+1 protein levels are known to increase. At higher concentrations, UBB+1 is known to inhibit the proteasome [42] and may therefore contribute to disease progression. In line with these results, UBB+1 accumulates in the neuropathological hallmarks of all types of AD patients [3941]. UBB+1 transgenic (tg) mice (line 3413) overexpress human UBB+1 specifically in neurons of the postnatal brain, with strongest neuronal expression in the forebrain [11]. In keeping with this, these mice have spatial and contextual memory deficits [11]. UBB+1 tg mice are currently the only mammalian in vivo model for long-term proteasome inhibition in the brain. However, in contrast to AD patients, no overt neuronal atrophy or degeneration has been observed in these mice. The expression of cerebral cortical proteins implicated in energy metabolism was altered, thus resembling AD in some aspects [11]. Consequently, as the central nervous system is a major regulator of body function, UBB+1 expression in brain might also indirectly affect the functioning of other organ systems. To further explore this, we extended our previous analysis of UBB+1 tg mice by a systematic phenotyping analysis in the German Mouse Clinic, which has been successfully used to discover novel and additional phenotypes [29]. Most interestingly, this approach revealed a respiratory dysfunction that was mirrored by transgenic UBB+1 expression in brainstem nuclei involved in breathing control. A similar distribution of UBB+1 expression was also observed in the same brain areas of AD patients. In addition to hippocampal transgene expression in line 3413, we found significant but mild changes in behavior and metabolic parameters of UBB+1 transgenic mice, which may be additional consequences of UBB+1 expression in brainstem areas [19]. These data are consistent with human anatomical data reporting that tangle formation appears early in subcortical brain areas such as the locus coeruleus [4531].


Materials and methods
Animal model and systematic phenotyping

UBB+1 overexpressing transgenic mice [UBB+1 tg, line 3413, 008833C57Bl/6.Tg(CaMK2α-UBB) 3413, Jackson #008833] [11] were kept on a C57BL/6J background and heterozygous transgenic mice were analyzed further. Non-transgenic littermates were used as controls. To ensure comparability among individuals, all mice were kept under standard animal housing conditions [e.g., bedding, specified pathogen free (SPF) conditions, light/dark cycle, and climate control] with food and water ad libitum. Mice were analyzed according to the primary systemic phenotyping approach in the German Mouse Clinic at two different ages of approximately 3 and 12 months as described below and elsewhere [16]. Secondary phenotyping screens to extend our primary findings were carried out at additional ages as described in the manuscript. Respiratory functions are presented in detail because these were the most significant effects identified by the primary screening protocol.

Respiratory function

Spontaneous breathing patterns of male and female mice (UBB+1 tg mice and controls) were studied at the ages of 3 (n = 6 for all four groups), 12 (n = 6 for all four groups) and 18 months (n = 8 for male tg mice and controls; females were not analysed). For the analysis of lung function and of the ventilatory response to hypercapnic and hypoxic conditions, males at the age of 18 months were studied (n = 8). A detailed description of the whole body plethysmography and the assessment of the lung function are provided in the supplementary methods. Statistical analyses were performed using a commercially available statistics package (Statgraphics®, Statistical Graphics Corporation, Rockville, MD, USA). Differences between groups were evaluated by Student’s t test. Statistical significance was assumed at p < 0.05. Data are presented as mean ± standard error of the mean (SEM).

Immunohistochemistry of mouse and human tissues

Eight 3-month-old, four 6-month-old, five 15-month-old male and four 18-month-old UBB+1 tg mice and three 3-month-old and three 15-month-old male control mice were given deep pentobarbital anesthesia (i.p.) and were perfused intracardially with phosphate-buffered saline (PBS) followed by PBS containing 4 % (w/v) paraformaldehyde (pH 7.4). Dissected brains were sectioned either coronally or sagittally in 50 μm thick sections with a Vibratome. Sections were stained with anti-UBB+1 antibody (Ubi3 16/09/97, final dilution 1:1,000) [10]. As controls for Ubi3 immunoreactivity, the Ubi3 antiserum was adsorbed with 6His tag UBB+1 and the pre-immune control serum was used (other controls were reported previously, [11]). In addition, an anti-14-3-3 zeta antibody (ζ, #1001) was generously supplied by A. Aitken (Edinburgh, UK) and tested on brain sections of UBB+1 tg mice (final dilution 1:500). After the primary antibody incubation, the sections were incubated with a biotinylated donkey anti-rabbit antibody followed by avidin–biotin–peroxidase and 3,3′-diaminobenzidine (DAB) intensified by 0.2 % nickel ammonium sulphate (pH 7.6). Photographs were made using the dotSlide BX51 microscope (Olympus, Japan).

Human postmortem tissue from AD patients and non-demented controls was obtained from the Radboud University Medical Centre (Department of Pathology, Nijmegen, The Netherlands, see Table 1). Brain tissues were fixed for 1 month after which the unembedded tissue was cut on a Vibratome in 50 μm thick sections. Sections were rinsed in TBS and subsequently treated with a graded series of methanol (20, 40, 60, 80 and 100 %, 10 min each), and back to 20 % methanol with 0.3 % H2O2 for 30 min and for 1 h in TBS. Sections were then incubated overnight at 4 °C with antibodies against misfolded Tau (MC1, 1:100, and UBB+1 (Ubi2A, 180398, 1:500). All dilutions were in 0.05 M Tris buffered saline (0.15 M with 0.25 M gelatin and 0.5 % Triton X-100, pH 7.4) [1041]. Subsequently, sections were incubated with donkey–anti-mouse or donkey–anti-rabbit antibodies (Jackson Laboratories), both biotinylated (1:400) and ABC (Vector, 1:400) and subsequently stained with DAB as described above.
Table 1 Clinico-pathological information of non-demented controls and AD patients

Number

Age (years)

Sex (F/M)

Braak stagea

Neurofibrillary tangles brainstemb

Amyloida

Brain weight (g)

LC

PBNl

1

52

M

0

+

0

1,424

2

59

F

0

+

0

1,523

3

87

M

3

++

Sparse

1,245

4

68

M

5

+++

++

Frequent

1,312

5

63

M

6

+++

++

Frequent

980

6

64

F

6

+++

++

Frequent

1,250

All specimens were fixed in 4 % buffered formalin for 6 weeks
LC locus coeruleus, PBNl lateral parabrachial nucleus, − no immunoreactivity of neurofibrillary tangles or neuropil threads, + minor immunoreactivity of neurofibrillary tangles or neuropil threads, ++ considerable immunoreactivity of neurofibrillary tangles or neuropil threads, +++ intense immunoreactivity of neurofibrillary tangles or neuropil threads
aBased upon examination of temporal cortex and hippocampus
bBased upon MC1 staining for misfolded Tau

Results
Systemic phenotyping in the German Mouse Clinic

The primary phenotyping protocol in the German Mouse Clinic (GMC) included the measurement of more than 240 parameters in the areas of allergy, behavior, bone and cartilage, cardiovascular diseases, clinical chemistry, energy metabolism, eye development and vision, immunology, respiratory function, molecular phenotyping, neurology, nociception, and pathology [131516]. As we expected that some mutant phenotypes might be associated with the aging process, UBB+1 tg mice and control animals were analyzed for phenotypes in two cohorts at the ages of about 3 and 12 months. Mice of both age cohorts were analyzed in the primary screening protocol within 8 weeks of the modal age. Significant phenotypic differences between UBB+1 tg and wild-type control mice that are presented here were found for respiratory function. In addition, we observed significantly altered parameters in metabolism, behavior and hippocampal gene expression, which are described in the supplementary information.

Spontaneous breathing patterns
Spontaneous breathing patterns were measured at rest and at activity, i.e., during calm sitting and short periods of sleeping and while animals were exploring the test chamber, respectively. Data were analyzed for each gender separately. At 3 months of age, significant genotype-dependent respiration differences between control mice and UBB+1 tg mice were detected for male mice during activity. In this group, the respiratory rate in UBB+1 tg mice was 8 % higher mostly due to a shorter expiratory time (Fig. 1a; S4). In addition, a slightly increased relative duration of inspiration was also observed in male UBB+1 tg mice compared to wild-type control mice (6 % increase, p < 0.001). The spontaneous breathing of UBB+1 tg mice was even more affected at the age of 12 months when respiratory timing was significantly altered in male UBB+1 tg mice during activity and at rest (Fig. 1b, c). The trend towards longer time of expiration and shorter relative duration of inspiration during aging was consistent among UBB+1 tg males (Fig. 1b, c; Fig. S5) and females (Fig. S1, S5) in comparison to the respective wild-type control groups. At 12 months of age, male UBB+1 tg mice exhibited significantly shorter relative duration of inspiration at rest (90 ± 3 %, Fig. 1b) and during activity (94 ± 3 %, Fig. 1c) compared to male wild-type control mice (set to 100 %). Since the inspiratory time and the mean inspiratory flow rate were not significantly affected in male UBB+1 tg mice (Fig. S5), the observed shorter relative duration of inspiration values was primarily due to an elevated expiratory time. The mean expiratory flow rate was significantly lower at rest (83 ± 4 %) and activity (91 ± 4 %) in UBB+1 expressing tg mice compared to the corresponding male control group (set to 100 %), which is most likely due to the differences in the expiratory time (Fig. 1b, c). Thus, overall the spontaneous breathing pattern of male transgenic UBB+1 mice was affected by a statistically significant increase of the expiratory time over age. In contrast, the male wild-type control group had a tendency towards reduced expiratory time over age. Female transgenic mice at 12 months of age and male transgenic mice at 18 months of age showed similar trends, which became significant for the latter (p < 0.05; Fig. S1, S2). Absolute values for the spontaneous breathing parameters are provided in the supplementary figures S4, S5 and S6.
MediaObjects/401_2012_1003_Fig1_HTML.gif
Fig. 1 UBB+1 tg spontaneous breathing patterns measured by whole body plethysmography. Male UBB+1 tg (black bars) and control mice (grey bars) at the age of a 3 months and bc 12 months were analyzed (n = 6 for all groups). a Shows the respiratory rate (f), expiratory time (Te), and relative duration of inspiration (Ti/TT) for male mice under activity. bc Show the mean expiratory flow rate (MEF), expiratory time (Te), and the relative duration of inspiration (Ti/TT) at the age of 12 months at rest and under activity, respectively. The mean values for the indicated parameters of the control group were set to 100 % and significance by Student’s t test is indicated by *p<0.05, **p<0.01, ***p < 0.001; error bars represent SEM

The altered spontaneous breathing pattern of the UBB+1 transgenic mice is not a mutant phenotype that causes obvious or severe suffering of the mice. The UBB+1 transgenic mice appear externally healthy and it is a mutant phenotype that is not apparent by gross inspection of the mice. However, within the primary lung screen of the German Mouse Clinic, which assesses the spontaneous breathing pattern by whole body plethysmography, we rarely observe such a consistent and clear mutant phenotype at least among mouse lines that externally appear rather normal.

To exclude the possibility that the observed differences in breathing patterns between transgenic and wild-type mice were merely caused by altered lung function per se, we tested various lung function parameters, including lung volume, mechanics, and gas exchange. None of the measured parameters were altered in UBB+1 tg mice compared to the wild-type control mice (Fig. S3), suggesting that differences in breathing pattern are not due to lung dysfunction per se but rather due to changes in respiratory regulation.

Breathing response to hypoxic and hypercapnic conditions

The breathing pattern of vertebrates with lung respiration is tightly controlled by the partial pressures of carbon dioxide and oxygen in the blood. Peripheral and central chemoreceptors ensure that increased concentrations of blood carbon dioxide (hypercapnia) or decreased levels of blood oxygen (hypoxia) result in increased respiratory efforts. To test the functionality of these feedback loops and to further examine the relevance of the observed changes in the spontaneous breathing pattern, 18-month-old UBB+1 tg and control mice were exposed to hypercapnic or hypoxic conditions.

Under hypoxic conditions, the most prominent response in all mice of the transgenic as well as the control group was observed for the tidal volume (Fig. 2b), which increased about 1.5-fold with 8 % O2 in the respiratory air in comparison to normal air (about 21 % O2). When hypoxic conditions were combined with hypercapnic conditions (3 % CO2 in the respiratory air), the tidal volume further increased almost twofold. The combined challenge of hypercapnic and hypoxic conditions also increased the relative duration of inspiration by about 170 % (Fig. 2d), indicating that it took the animals more time to inhale the increased tidal volume. All values returned to baseline conditions within a 15-min recovery period. Even though UBB+1 tg animals and control mice showed a similar increase in tidal volume under hypoxic conditions at 8 % O2, they showed significant differences in two other parameters under this condition. Thus, the respiratory rate in UBB+1 tg mice declined to about 75 % at 8 % O2 (206.7 ± 8.3 min−1) whereas this parameter was only slightly changed in control animals (about 90 %; 246.8 ± 8.4 min−1p < 0.001; Fig. 2a). Secondary to this, the minute ventilation was also significantly lower in UBB+1 tg mice (Fig. 2c; p < 0.01). Interestingly, when adding the hypercapnic challenge of 3 % CO2 in the breathing air to the hypoxic challenge, the breathing patterns of UBB+1 tg and controls were not significantly different (Fig. 2a, c). In addition, we examined breathing patterns of mice exposed to 3, 5 and 8 % CO2 in the air (at normal oxygen conditions). Under these conditions, we did not observe differences between UBB+1 tg animals and wild-type mice (Fig. S7). These findings support the notion that the hypoxic response is primarily affected in UBB+1transgenic mice. In contrast, the feedback loop for CO2 levels is apparently not affected in UBB+1 transgenic mice.
MediaObjects/401_2012_1003_Fig2_HTML.gif
Fig. 2 Ventilatory responses to hypoxic and hypercapnic conditions are affected by UBB+1 expression. Male mice at the age of 18 months (n = 8 for each group) were exposed to 10 and 8 % O2 (hypoxia) followed by a combined exposure of 8 % O2+3 % CO2 (hypoxia and hypercapnia) each for 7 min and a recovery period of 15 min. a Shows the respiratory rates (f), b shows the tidal volume (TV), c shows the minute ventilation (MV), and d shows the relative duration of inspiration time (Ti/TT). Values were calculated relative to baseline levels (set to 100 %) and significance by Student’s t test is indicated by ****p<0.001, ***p<0.01; error bars represent SEM. The response to hypercapnic conditions is shown in Supplementary Figure S7

Anatomic localization of UBB+1 in the mouse brain
The expression of UBB+1 in brain sections of UBB+1 tg mice was examined using the UBB+1-specific Ubi3 antibody (bleeding 16-9-97) and a more sensitive procedure (avidin–biotin method) than previously used [11]. In the present study, hippocampal fibers in the CA region were positive, especially in the CA2 region (Fig. 3a, b). The intense fiber staining in the region where the CA3 borders the CA2 appears to reflect an increased fiber density. The incubation of mouse brain tissue with 6His tag UBB+1 and the pre-immune control serum resulted in an absence of immunopositive staining (data not shown). There was no staining in the brains of wild-type control mice.
MediaObjects/401_2012_1003_Fig3_HTML.jpg
Fig. 3 Immunohistochemical expression of UBB+1 in the brain of tg mice. UBB+1 staining of ab hippocampus and ch brainstem of male UBB+1 tg mice at the age of 15 months (hippocampus) and 3 months (brainstem) with the Ubi3 antibody (sagittal section, a/b). Hippocampal cells are immunoreactive for UBB+1. The fibers widespread in the hippocampus are also stained (see boxed area in a), especially in the region where the CA3 borders the CA2 (asterisk). Another region of more intense UBB+1 staining reflects the stratum lacunosum (arrowhead), apparently with crossing fibers of the perforant pathway. Sagittal (c,d) and coronal (eh) sections of UBB+1 tg mice were incubated with Ubi3. c Note the expression of UBB+1 in the dorsal vagal complex (nucleus tractus of the solitarius, area postrema, dorsal motor nucleus of vagus nerve). d Region of dorsal vagal complex as indicated by the boxed area in c at a higher magnification. e Coronal section shows again the expression of UBB+1 in the dorsal vagal complex and f shows this region (boxed area in e) at a higher magnification. Note in e UBB+1 immunostaining in the spinal 5 nucleus. g Note the expression of UBB+1 in neurons of the different subnuclei of the parabrachial nucleus (boxed area). h Photograph of parabrachial nucleus at a higher magnification. Nomenclature based upon [14]. Abbreviations see paper. Scalesa = 200 μm, b = 20 μm, c = 1 mm, d = 100 μm, e = 500 μm,f = 100 μm, g = 1 mm, h = 100 μm

The present immunohistochemical staining procedure also enabled a superior anatomic localization of UBB+1 in other brain regions as compared to our previously published results [11]. In particular, in the brainstem of UBB+1 tg mice labeling with the Ubi3 antibody was prominent in regions associated with known functions in respiratory modulation (Fig. 3c–h). Both in the dorsal respiratory group (Fig. 3c–f) and the pneumotaxic center (Fig. 3g, h), UBB+1 immunoreactive nuclei were found. In UBB+1 tg animals, UBB+1 was present in specific areas of the dorsal vagal complex, such as the area postrema (AP), the nucleus of the tractus solitarius (NTS), and the dorsal motor nucleus of the vagus nerve (Fig. 3c–f). Strongly positive UBB+1 immunoreactive neurons were also present in the locus coeruleus (LC) and subnuclei of the parabrachial nucleus (PBN) (Fig. 3g, h), especially in the external lateral (PBNel) and dorsal lateral (PBNdl) subnuclei, which receive visceral inputs from the caudal NTS. The rodent external lateral nucleus is involved in respiratory function and in the modulation of respiratory responses to hypoxia and hypercapnia [3536]. In particular, the central respiratory control of the response to hypoxia was affected in UBB+1 tg mice (Fig. 2). These findings are consistent with the hypothesis that highly elevated UBB+1expression might have mild toxic effects that could interfere with the normal neuronal function [42]. Mice were analyzed for UBB+1 expression at the ages of 3, 6, 15 and 18 months, but no differences among the four ages were found with respect to UBB+1 immunohistochemical staining, which is in agreement with previously published data [11].

Anatomic localization of UBB+1 in the human brain
In the brainstem of sporadic AD patients (Braak stage #6 and less prominent in stages #3 and #5) comparable nuclei as in the UBB+1 tg mouse line 3413 mouse were stained positively for misfolded Tau and UBB+1 in the pneumotaxic centers of the brain (Fig. 4a–g), e.g., in the locus coeruleus, subcoeruleus, the lateral and medial parabrachial nuclei, the subpeduncular pigmented nucleus and the sagulum. Many neurofibrillary tangles, kinky and curly fibers can be seen (Fig. 4b, f, g). In the dorsal respiratory group, UBB+1 immunoreactivity was found in the nuclei surrounding the solitary tract (Fig. 4h, i). These stainings were not observed in stages #0. Also in the medulla, various nuclei around the solitary tract were immunoreactive for misfolded Tau (Fig. 4h–j) and UBB+1 (Fig. 4k, l). These anatomical data support the possibility of respiratory dysfunction in AD.
MediaObjects/401_2012_1003_Fig4_HTML.jpg
Fig. 4 Immunohistochemical expression for misfolded Tau and UBB+1 in the human brainstem. Intense staining (MC1) for misfolded Tau (acfhj) and UBB+1 (cgkl) in various nuclei of the brainstem of patient # 5 (Braak stage 6). ac Oral pons (Obex ± 25 mm, [32]) and dg Oral pons (Obex ± 30 mm). be and f are larger magnifications of a and d respectively, as indicated by the boxes in a and d. Neurofibrillary tangles (asterisk) and neuropil threads (filled triangle) are stained in the locus coeruleus (LC), the medial (PBNm) and lateral parabrachial nucleus (PBNl). The PBNl is located between the superior cerebellar peduncle (scp) and the lateral lemniniscus (ll). The PBNm and subpeduncular pigmented nucleus (SPP) are located, medially and ventrolaterally respectively, to the scp. hl More caudally in the medulla (Obex ± 5 mm) the ventral (SolM), dorsolateral (SolDL), other solitary subnuclei and the dorsal motor nucleus of the vagus show neurofibrillary tangles (hj), that are UBB+1 positive (kl). i is a larger magnification of the boxed area in (h). Note brown neuromelanin inclusions in hlSAG sagulum, sol solitary tract. Scalesadgh = 500 μm; efik = 200 μm; bc = 100 μm; l = 30 μm. Asterisk, neurofibrillary tangles by MC1 staining; filled triangle, neuropil threads


Discussion

The precise role of the UPS in neurodegeneration and aging is not clear, but the partial impairment of its function in the mouse brain results in spatial memory deficits and changes in fear-related behavior [112428]. In the present study, we extended these data using additional behavioral tests on UBB+1 tg mice (see also supplementary data) and report further phenotypic differences. Moreover, the intensity of the UBB+1 staining was remarkably enhanced by the improved immunohistochemical staining protocol enabling better localizations (Fig. 3a, b). Our data suggest that neurons involved in the central control of respiration are sensitive to long-term UPS inhibition via the expression of the UBB+1 protein. Although the observed differences were significant, the postnatal transgenic expression of UBB+1 seems to be rather well tolerated by mice, because the vast majority of the more than 240 parameters measured in the primary phenotyping protocol of the German Mouse Clinic did not show significant differences in comparison to control animals. This limited transgenic phenotype is in accordance with previous studies [11] where no signs of protein aggregations, neurodegeneration or other histological changes were observed. This finding might be explained by the rather modest reduction of proteasomal activity (at least 20 %) in brain tissue of UBB+1 tg mice [11]. The UBB+1 tg mouse line is to our knowledge the only existing in vivo model for the long-term, low level inhibition of the UPS. This feature models the human situation during aging and neurodegeneration, where chronic reduction of the UPS activity is observed [25]. To approximate the situation in humans, our systematic phenotyping was done with UBB+1 tg mice at 3 and 12 months of age. In both age groups, the same biological functions, namely respiratory function, behavior and metabolism were affected in the UBB+1 transgenic mice. In contrast to humans, a dramatic increase in the severity of the transgenic phenotype with age was not observed, which is in line with previous results [11] and which may be related to the relatively short life span of mice.

UBB+1 phenotype affects respiratory function

The key findings of the respiratory function analysis were related to altered breathing patterns particularly in male UBB+1 tg mice, which affected the respiratory rate and respiratory timing. Respiratory timing was predominantly affected by a reduction of the relative duration of inspiration (Ti/TT) in combination with an increased expiratory time (Te). An affected breathing pattern per se is a rather unspecific finding, which could be due to several factors, (1) altered central breathing control, (2) impaired sensitivity of peripheral chemoreceptors, (3) altered respiratory muscle function, or (4) affected respiratory function per se. To address these different issues, we tested UBB+1 tg mice for respiratory lung function (lung volumes, mechanics, and gas exchange) and the ventilatory response to hypercapnic and hypoxic conditions, respectively. With regard to lung function, the parameters were not different in UBB+1 tg and wild-type mice. These findings indicated that the increased expiratory time is not related to an increased airway resistance that the gas exchange function of the respiratory system per se (4) is not affected by UBB+1 transgenic overexpression and that the alterations in breathing pattern are not caused by impaired respiratory muscle function (3). This conclusion is further supported by the hypercapnic and hypoxic challenge responses. A similar increase up to a factor of 2 in tidal volume in controls and UBB+1 tg mice was observed indicating that UBB+1tg animals have normal thoracic muscle strength. To further distinguish between central (1) and peripheral (2) chemoreceptor sensitivity, mice were exposed to hypercapnic and/or hypoxic conditions and the ventilatory response was measured. The results show that the hypercapnic response was not affected in UBB+1 tg mice, while the hypoxic response was. UBB+1 tg mice showed declining respiratory rates with increasing levels of hypoxia, being 16.3 % lower than in controls at 8 % O2. As a result, minute ventilation was also significantly lower in UBB+1 tg mice. Interestingly, breathing differences between UBB+1 tg and control mice were virtually absent when the hypercapnic challenge of 3 % CO2 was added to the hypoxic challenge. This supports the conclusion that primarily the hypoxic feedback loop is affected in UBB+1 tg mice. Hence, these experimental results suggest that an altered central breathing control (1) is the most likely explanation for the observed phenotype.

In support of this hypothesis, we observed strong UBB+1 tg expression in various brainstem nuclei which are involved in the regulation of respiratory function. For example, the nucleus of the solitary tract (NTS), which is part of the dorsal respiratory group, was UBB+1 immunoreactive in all the different subnuclei. The caudal part of this nucleus receives afferent information from baroreceptors, mechanoreceptors and from central and peripheral chemoreceptors. Furthermore, it has been shown that the AP together with NTS project to the PBN [20], which comprises a second respiratory center positive for UBB+1 expression. Specifically, the external lateral and dorsal lateral PBN subnuclei were strongly UBB+1 immunoreactive. It has been reported that the external lateral PBN subnucleus in rodents has an important role in the respiratory response to hypoxic and hypercapnic conditions [3536]. This is of particular interest because UBB+1 tg mice showed differences in their response to hypoxia compared to the controls. Interestingly, it has previously been shown that the locus coeruleus area and the PBN are among the early targets of the AD-related cytoskeletal pathology, which suggests that parts of the brainstem respiratory centers are affected during AD progression [433]. UBB+1 tg mice are not the only mouse model with altered respiration. For example, Tau-P301L transgenic mice show a breathing phenotype, which can be linked to Tau (Mapt) expression in defined nuclei of the brainstem such as the Kölliker-Fuse nucleus [829]. Apart from respiratory dysfunction, swallowing impairments are common in AD patients and frequently lead to aspiration pneumonia [23]. The three phases of swallowing (oral, pharyngeal and esophageal) are regulated by central pattern generators in the brainstem and one of them is the NTS [27]. This suggests that there might be a functional link between the respiratory changes exhibited by the UBB+1 tg mice and the respiratory and swallowing dysfunctions in AD patients, because similar anatomical regions are affected as we have shown in our examination of the distribution of UBB+1 in the brains of AD patients. Intriguingly, it was also recently shown that the minute volume in AD patients under peak exercise conditions is reduced in comparison to a non-demented control group [3]. Our data suggest that this change in respiratory response in AD patients could also be due to a dysfunction of central breathing control.

Conclusions

Our comprehensive phenotyping approach revealed a respiratory phenotype in UBB+1 tg mice, which prompted us to perform an extensive immunohistochemical UBB+1 analysis of the brainstem of these mice. In several areas involved in respiratory regulation such as the lateral parabrachial nuclei [3536] and the dorsal vagal complex, we detected intense UBB+1 immunoreactivity. Our data suggest that also in other AD mouse models respiratory function analysis needs to be addressed.

As UBB+1 tg mice are an animal model for early AD, we subsequently analyzed UBB+1 expression in AD patients and healthy individuals. In the human brainstem, UBB+1 immunoreactivity and misfolded Tau were seen in similar areas as in UBB+1 tg mice and they may well contribute to the selective vulnerability of the brainstem to AD [31]. A role of the lateral parabrachial nucleus in mediating the feedback control of inspiratory drive has been reported [35]. The dorsal respiratory group communicates with this area and shows UBB+1 immunoreactivity as well. It could well be that breathing dysfunction may play a major role in cognitive, behavioral and emotional impairments in early onset AD [22]. Also, a disproportional contribution of bronchopneumonia as a cause of death in AD patients is consistent with our findings that indicate breathing dysfunction as a contributing factor. With respect to respiratory function in aged patients and during AD per se, it has been noted that increased cardiorespiratory fitness in early-stage AD is associated with reduced brain atrophy as compared with non-demented individuals [6]. Moreover, it was recently reported that aerobic exercise has positive effects on mild cognitive impairment (e.g., [1]), underscoring the need to enhance respiratory function. Together with these published observations, our data might suggest that the examination of the respiratory system could be an important parameter for monitoring the progression of AD. It remains to be analyzed whether other cognitive disorders also display UBB+1 expression and neuronal pathology in central breathing control regions.

Acknowledgments  We would like to thank Christiane Lach and Constanze König for their excellent technical assistance and Jan Ruijter (Academic Medical Center, Amsterdam) for assistance with gene profiling. Dr. R.A.I. de Vos (Laboratory of Pathology, Enschede, The Netherlands) advised on human brainstem anatomy. Human postmortem tissue was obtained from Dr. B. Küsters (Radboud University, Nijmegen, The Netherlands). We thank Prof. Kay Hofmann (Universität Köln, Germany) for providing an UPS-related gene set. The study was funded by BMBF through a grant from NGFN2 (Human Brain Proteome Project) subproject FKZ01GR0448 to JB and through NGFN-Plus (01GS0850 to MHA, 01GS0869 to MK). F.W. Van Leeuwen was supported by ISAO (# 06502 and 09514), Hersenstichting Nederland (2008.17 and 15F07.48), IPF 2008 and Van Leersum Foundation KNAW 2011. D.A. Hopkins was supported by an ISAO Visiting Professorship.
Conflict of interest  
The authors declare no actual or potential conflicts of interest.
Ethical standard  
Animals were handled according to ethical guidelines.
Open Access  
This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.

Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary material 1 (DOC 1950 kb)


References

1. Baker LD, Frank LL, Foster-Schubert K, Green PS, Wilkinson CW, McTiernan A, Plymate SR, Fishel MA, Watson GS, Cholerton BA et al (2010) Effects of aerobic exercise on mild cognitive impairment: a controlled trial. Arch Neurol 67:71–79
PubMed CrossRef
 
2. Beckers J, Wurst W, de Angelis MH (2009) Towards better mouse models: enhanced genotypes, systemic phenotyping and envirotype modelling. Nat Rev Genet 10:371–380
PubMed CrossRef ChemPort
 
3. Billinger SA, Vidoni ED, Honea RA, Burns JM (2011) Cardiorespiratory response to exercise testing in individuals with Alzheimer’s disease. Arch Phys Med Rehabil 92:2000–2005
PubMed CrossRef
 
4. Braak H, Del Tredici K (2011) The pathological process underlying Alzheimer’s disease in individuals under thirty. Acta Neuropathol 121:171–181
PubMed SpringerLink
 
5. Braak H, Thal DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70:960–969
PubMed CrossRef ChemPort
 
6. Burns JM, Mayo MS, Anderson HS, Smith HJ, Donnelly JE (2008) Cardiorespiratory fitness in early-stage Alzheimer disease. Alzheimer Dis Assoc Disord 22:39–46
PubMed CrossRef
 
7. De Pril R, Fischer DF, Maat-Schieman ML, Hobo B, de Vos RA, Brunt ER, Hol EM, Roos RA, van Leeuwen FW (2004) Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases. Hum Mol Genet 13:1803–1813
PubMed CrossRef
 
8. Dutschmann M, Menuet C, Stettner GM, Gestreau C, Borghgraef P, Devijver H, Gielis L, Hilaire G, Van Leuven F (2010) Upper airway dysfunction of Tau-P301L mice correlates with tauopathy in midbrain and ponto-medullary brainstem nuclei. J Neurosci 30:1810–1821
PubMed CrossRef ChemPort
 
9. Enard W, Gehre S, Hammerschmidt K, Holter SM, Blass T, Somel M, Bruckner MK, Schreiweis C, Winter C, Sohr R et al (2009) A humanized version of Foxp2 affects cortico-basal ganglia circuits in mice. Cell 137:961–971
PubMed CrossRef ChemPort
 
10. Fischer DF, De Vos RA, Van Dijk R, De Vrij FM, Proper EA, Sonnemans MA, Verhage MC, Sluijs JA, Hobo B, Zouambia M et al (2003) Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain. FASEB J 17:2014–2024
PubMed CrossRef ChemPort
 
11. Fischer DF, van Dijk R, van Tijn P, Hobo B, Verhage MC, van der Schors RC, Li KW, van Minnen J, Hol EM, van Leeuwen FW (2009) Long-term proteasome dysfunction in the mouse brain by expression of aberrant ubiquitin. Neurobiol Aging 30:847–863
PubMed CrossRef ChemPort
 
12. Fonseca R, Vabulas RM, Hartl FU, Bonhoeffer T, Nagerl UV (2006) A balance of protein synthesis and proteasome-dependent degradation determines the maintenance of LTP. Neuron 52:239–245
PubMed CrossRef ChemPort
 
13. Fuchs H, Gailus-Durner V, Adler T, Aguilar-Pimentel JA, Becker L, Calzada-Wack J, Da Silva-Buttkus P, Neff F, Gotz A, Hans W et al (2011) Mouse phenotyping. Methods 53:120–135
PubMed CrossRef ChemPort
 
14. Fulwiler CE, Saper CB (1984) Subnuclear organization of the efferent connections of the parabrachial nucleus in the rat. Brain Res 319:229–259
PubMed ChemPort
 
15. Gailus-Durner V, Fuchs H, Adler T, Aguilar Pimentel A, Becker L, Bolle I, Calzada-Wack J, Dalke C, Ehrhardt N, Ferwagner B et al (2009) Systemic first-line phenotyping. Methods Mol Biol 530:463–509
PubMed SpringerLink ChemPort
 
16. Gailus-Durner V, Fuchs H, Becker L, Bolle I, Brielmeier M, Calzada-Wack J, Elvert R, Ehrhardt N, Dalke C, Franz TJ et al (2005) Introducing the German Mouse Clinic: open access platform for standardized phenotyping. Nat Methods 2:403–404
PubMed CrossRef ChemPort
 
17. Gerez L, de Haan A, Hol EM, Fischer DF, van Leeuwen FW, van Steeg H, Benne R (2005) Molecular misreading: the frequency of dinucleotide deletions in neuronal mRNAs for beta-amyloid precursor protein and ubiquitin B. Neurobiol Aging 26:145–155
PubMed CrossRef ChemPort
 
18. Goedert M (2001) Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2:492–501
PubMed CrossRef ChemPort
 
19. Heneka MT, Ramanathan M, Jacobs AH, Dumitrescu-Ozimek L, Bilkei-Gorzo A, Debeir T, Sastre M, Galldiks N, Zimmer A, Hoehn M et al (2006) Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. J Neurosci 26:1343–1354
PubMed CrossRef ChemPort
 
20. Herbert H, Moga MM, Saper CB (1990) Connections of the parabrachial nucleus with the nucleus of the solitary tract and the medullary reticular formation in the rat. J Comp Neurol 293:540–580
PubMed CrossRef ChemPort
 
21. Hershko A, Heller H, Elias S, Ciechanover A (1983) Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown. J Biol Chem 258:8206–8214
PubMed ChemPort
 
22. Hilaire G, Voituron N, Menuet C, Ichiyama RM, Subramanian HH, Dutschmann M (2010) The role of serotonin in respiratory function and dysfunction. Respir Physiol Neurobiol 174:76–88
PubMed CrossRef ChemPort
 
23. Humbert IA, McLaren DG, Kosmatka K, Fitzgerald M, Johnson S, Porcaro E, Kays S, Umoh EO, Robbins J (2010) Early deficits in cortical control of swallowing in Alzheimer’s disease. J. Alzheimer’s Dis 19:1185–1197
 
24. Hung AY, Sung CC, Brito IL, Sheng M (2010) Degradation of postsynaptic scaffold GKAP and regulation of dendritic spine morphology by the TRIM3 ubiquitin ligase in rat hippocampal neurons. PLoS One 5:e9842
PubMed CrossRef
 
25. Keller JN, Hanni KB, Markesbery WR (2000) Impaired proteasome function in Alzheimer’s disease. J Neurochem 75:436–439
PubMed CrossRef ChemPort
 
26. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile Parkinsonism. Nature 392:605–608
PubMed CrossRef ChemPort
 
27. Lang IM (2009) Brain stem control of the phases of swallowing. Dysphagia 24:333–348
PubMed SpringerLink
 
28. Mardirossian S, Rampon C, Salvert D, Fort P, Sarda N (2009) Impaired hippocampal plasticity and altered neurogenesis in adult Ube3a maternal deficient mouse model for Angelman syndrome. Exp Neurol 220:341–348
PubMed CrossRef ChemPort
 
29. Menuet C, Borghgraef P, Matarazzo V, Gielis L, Lajard AM, Voituron N, Gestreau C, Dutschmann M, Van Leuven F, Hilaire G (2011) Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer’s disease. Respir Physiol Neurobiol 178:290–303
 
30. Mori H, Kondo J, Ihara Y (1987) Ubiquitin is a component of paired helical filaments in Alzheimer’s disease. Science 235:1641–1644
PubMed CrossRef ChemPort
 
31. Parvizi J, Van Hoesen GW, Damasio A (2001) The selective vulnerability of brainstem nuclei to Alzheimer’s disease. Ann. Neurol 49:53–66
PubMed CrossRef ChemPort
 
32. Paxinos G, Huang XF, Sengul G, Watson C (2012) Organization of human brainstem nuclei. In: Mai JG, Paxinos G (eds) The human nervous system, Elsevier Academic Press, London, pp 260–327
 
33. Rüb U, Del Tredici K, Schultz C, Thal DR, Braak E, Braak H (2001) The autonomic higher order processing nuclei of the lower brain stem are among the early targets of the Alzheimer’s disease-related cytoskeletal pathology. Acta Neuropathol 101:555–564
PubMed
 
34. Setsuie R, Wada K (2007) The functions of UCH-L1 and its relation to neurodegenerative diseases. Neurochem Int 51:105–111
PubMed CrossRef ChemPort
 
35. Song G, Poon CS (2009) Lateral parabrachial nucleus mediates shortening of expiration and increase of inspiratory drive during hypercapnia. Respir Physiol Neurobiol 165:9–12
PubMed CrossRef
 
36. Song G, Poon CS (2009) Lateral parabrachial nucleus mediates shortening of expiration during hypoxia. Respir Physiol Neurobiol 165:1–8
PubMed CrossRef
 
37. Trujillo G, Nakata K, Yan D, Maruyama IN, Jin Y (2010) A ubiquitin E2 variant protein acts in axon termination and synaptogenesis in Caenorhabditis elegans. Genetics 186:135–145
PubMed CrossRef ChemPort
 
38. Van Den Hurk WH, Willems HJ, Bloemen M, Martens GJ (2001) Novel frameshift mutations near short simple repeats. J Biol Chem 276:11496–11498
CrossRef
 
39. Van Leeuwen FW, de Kleijn DP, van den Hurk HH, Neubauer A, Sonnemans MA, Sluijs JA, Koycu S, Ramdjielal RD, Salehi A, Martens GJ et al (1998) Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer’s and Down patients. Science 279:242–247
PubMed CrossRef
 
40. Van Leeuwen FW, Fischer DF, Kamel D, Sluijs JA, Sonnemans MA, Benne R, Swaab DF, Salehi A, Hol EM (2000) Molecular misreading: a new type of transcript mutation expressed during aging. Neurobiol Aging 21:879–891
PubMed CrossRef
 
41. Van Leeuwen FW, van Tijn P, Sonnemans MA, Hobo B, Mann DM, Van Broeckhoven C, Kumar-Singh S, Cras P, Leuba G, Savioz A et al (2006) Frameshift proteins in autosomal dominant forms of Alzheimer disease and other tauopathies. Neurology 66:S86–S92
PubMed CrossRef
 
42. Van Tijn P, de Vrij FM, Schuurman KG, Dantuma NP, Fischer DF, van Leeuwen FW, Hol EM (2007) Dose-dependent inhibition of proteasome activity by a mutant ubiquitin associated with neurodegenerative disease. J Cell Sci 120:1615–1623
PubMed CrossRef
 
43. Yi JJ, Ehlers MD (2007) Emerging roles for ubiquitin and protein degradation in neuronal function. Pharmacol Rev 59:14–39
PubMed CrossRef ChemPort
 

学科代码:神经病学   关键词:Alzheimer’s disease Mouse model Ubiquitin B (UBB+1) Ubiquitin–proteasome system (U Hypoxic response Central breathing control
来源: ACTA NEUROPATHOLOGICA`
顶一下(0
您可能感兴趣的文章
    发表评论网友评论(0)
      发表评论
      登录后方可发表评论,点击此处登录
      友情链接: Elsevier Global site | ClincalKey  | Journals CONSULT |Procedures CONSULT | Clinical Pharmacology  | 3D Interact Anatomy  | NursingChina | eClips CONSULT | 中文版柳叶刀 
       好大夫  |  医师网  | 丁香园  | 论文吧  | 世界医学书库  | 好医生论坛  |  医心网  | 环球医学  | 白天使  | 医脉通 | 中华外科杂志  | 中国妇产科网  |  新青年麻醉论坛  | 杏树林  | 医学论坛网  | 春雨掌上医生  |协和青年之家 | More>